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Abstract
Birth defect (congenital defect / congenital condition) is an anomaly appearing at birth
and able to cause the physical or mental defect or death. Birth defect generally can be
detected during the prenatal period. However, if this cannot be detected during the
prenatal period, it can be identified at the post natal examination. Congenital Bilateral
Absence Vas Difference (CBAVD) is of one the congenital defects characterized by
Azoospermia causing the occurrence of infertility. This congenital defect can bring
impact to the structural, functional and metabolism anomalies. Approximately 7.9
million children in the world (about 6% of the whole anomalies in the world) were
born with serious congenital defects every year due to genetic anomaly or other
post-conception. The determination of optimal output from PCR optimization to obtain
the location of ΔF 508-T mutant on CBAVD patients in Indonesia is conducted pursuant
to the gene target. The conclution were influence of various factors as the indicator
specifying the mutation of ΔF 508-T mutant needs to be considered in making a
decision for the preliminary research on CBAVD in Indonesia.
1. INTRODUCTION
The Congenital Bilateral Advance Vass Diferens (CBAVD) is one of the congenital
defects characterized by Azoospermia. The rate of CBAVD occurrence is certainly very
small, namely around 2–10%.
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This congenital defect can bring impact to the anomaly in structure, function or
metabolism. Each year about 7.9 million children all over the world (approximately
6% of the whole births in the world) are born with serious congenital defects due to
genetic anomaly or other post conceptual causes, such as alcoholic, rubella, syphilis,
iodine deficiency and the like. According to Center for Disease Control and Prevention
(CDC), each year in USA about 3% of the children are born with various congenital
defects and about 1 out of 5 (five) babies with the congenital defects will death on the
first year of their life. There is still no data about the case of CBAVD congenital diseases
in Indonesia. The CBA patients have high rate of success and relatively lower level of
morbidity. The infertility onmen still becomes the case not yet been thoroughly settled
in Medical Science, so that the priority is not only given to carry out the genetic test
to the patients, but also the etiology identification and counseling should already have
been socialized to prevent the transmission of genetic defects through ART – Assisted
Reproductive Technology.
It is expected that with the activation of the Assisted Reproductive Technology, the
evaluation on infertility on men either syndrome or non-syndrome through the Diag-
nostic Test will be more improved (Dada, 2011). The causes of infertility on men have
been investigated and examined by Hotchkiss since the Year 1944 through various
researches already been conducted till finally the case of CBAVD was found in South
America by Michelson et al., 1949. The recommended data on various genetic test
on infertility cases focused on the examination outputs on abnormal spermatozoa,
either quantitatively or qualitatively caused by the genetic mutation based on their
phenotype and their genotypes constitutes the CBAVD patients (67%) accompanied
by the presence of CFTR. (Dada, 2011).
The research development on CBAVD at the international level has started since the
year 1968 by the finding of an American man who died due to an abscess growing
bigger and bigger at the scrotum and the formation of fibrosis cystic already been
metastasis at various organs, particularly at pancreas, lung, liver and his death was
presumed due to the immunodeficiency. (Wang et al., 2002).
2. METHOD OF RESEARCH
PBMC experimental unit is taken from one person declared suffering from CBAVD. The
RNA isolation was conducted to see the expression of CFTR gene, the mRNA available
inside the cell indicating the presence of CFTR protein. In order to obtain the DNA, the
RNA has to be changed first to be cDNA. The established DNA is then transferred to
plasmid.
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The execution of this research is classified into 4 stages namely: First, isolation,
characterization and culture of PBMC. Second, DNA transfection into the target cell.
Third, CFTR gene design as prototype resistant to CBAVD infection. Fourth, analysis on
the resistance to CBAVD infection. The proposal of research is presented to the Ethical
Commission of LPPM (Institution of Research and Community Dedication) of Airlangga
University. Having been approved, the UE is taken from PBMCs of the person suffering
from CBAVD. UE is isolated by 1.077 Ficoll gradient and hermatopoetic culture cell. Then,
the degree of mRNA is identified. Further, the mRNA extraction is carried out at PCR.
If the PCR is positive, a purification is carried out again and given the labeling and
sequencing.
3. Polymerase Chain Reaction (PCR)
PCR is conducted through several stages, namely: DNA extraction, amplification and
electrophoresis. The DNA extraction is conducted from culture cell in which the culture
cell at the amount of 103 cells at the final volume of 200 µl buffer B3 (a mixture of B1
(containing Guanidin Hydrochloride) and B2) is incubated at the temperature of 70∘C
for 10 – 15 minutes. Further, it is added with 96% ethanol at the amount of 210 µl, then
given the vortex
The next step is BNA bind. This mixture is entered into the column then centrifuged
11,000 g for 1 minute. The liquid at the bottom is discharged and cleaned twice (2x).
First, by adding 500 µl buffer BW (Guanidin Hydrochloride and Isoprotenol <25%) then
centrifuged 11,000 g for 1 minute then discharged. The second cleaning is conducted
by adding 600 µl buffer B5, then centrifuged for 1 minute. The entering liquid into the
collecting tube is discharged (Rantam et al., 2011). Centrifugal rotation of 11,000 g is
repeated for 1minute to clean up the ethanol. Then the Column is put into the 1.5ml tube
eppendorf and addedwith 100 µl elution buffer already been heated at the temperature
of 70∘C and incubated for 1 minute, then centrifuged 11,000 g for 1 minute. In princi-
ple, PCR consists of three stages, namely: denaturalization of multiple chain of DNA,
then primary annealing (attachment) to DNA of its target. The last stage is the primary
extension due to the presence of DNA polymerase. The DNA output is the exponential
accumulation of the specific DNA target. There are 3 stages in amplification, namely
denaturalization conducted by means of incubation at waterbath at the temperature
of 95∘C. The next stage is annealing, namely the attachment process of primary to the
template conducted at the temperature of 47∘C. The last is the extension stage, namely
the extension process of nucleotide base chain at the temperature of 72∘C so that 2
new multiple chains of DNA are established.
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Immunoglobulin G and Immunoglobulin A is carried out at the research.
Immunoglobulin or antibody is a group glycoprotein available at the serum or liquid at
the body of almost all the mammalians. Immunoglobulin includes in the glycoprotein
family having the same basic structure, consisting of 82-96% of polypeptide and 4-
18% of carbohydrate. The polypeptide component brings the aforesaid biologic nature
of antibody molecules. The immunoglobulin A (IgA) is the antibody found at the parts
of body, such as at the nose, respiratory channel, digesting channel, ears, eyes, and
vagina. The IgA antibody protects the surface of the body from the foreign substance
from outside. This type of antibody is also found at the saliva, tears and blood. About
10% till 15% of antibody inside the body is the IgA antibody. A small amount of people
do not produce the IgA antibody.
The Adenovirus examination is carried out to detect the CBAVD case caused by
the Adenovirus. Adenovirus can have latent nature in its host for several years. The
presence of protein penton from adenovirus with the virulent nature on its host without
any synthesis hindrance from the cell, so that it causes the cell released and sepa-
rated from the monolayers. The latent nature of adenovirus has to be taken into our
attention. Although its clinical symptoms are frequently non-visible at the patients,
the virus remains exists at the body of the patients. In general, the virus can be found
at the lymphoid tissue (lymph gland, tonsil, and peyer’s patches). The Adenovirus virus
examination is conducted to prove that the CBAVD case is caused by Adenovirus of
genetic defect.
4. RESULTS
The structure of growth or development and reproduction functions of organism
depends on protein materials available in every cell and tissue. A protein consists
of one or more chains of amino acids. Each chain of amino acid is called ‘polypeptide’,
and the sequence of amino acids in polypeptide chain is coded by a gene. Not all genes
become the protein synthesis, so that not all gene transcriptions constitute RNA which
is then translated.
Figure 1: The reseach trial with different three primer are C cDNA (red), M cDNA
(yellow) and N cDNA (blue) to obtain many kinds primer that available to detect cDNA
level accuratedly with amplificatons, The reprecentative primer is N cDNA (blue) and
un representative is C cDNA (red)
Figure 2. Replication of PCR was done several times to obtain optimum band that
appropiate with PCR result of Werstern people
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T 1: The result of measurement RNA level in CBAVD patient.
Measurement Level
Wavelenght (1) 260 nm
Absorbance 0,121 ÃU
Wavelenght (2) 280 nm
Absorbance (2) 0,099 ÃU
Concentration 0.1214 µg / ml × 200 = 24,28 µg / ml
Dilution Factor 1.0000
Level of Cdna Ã 260 / Ã 280 = 1,2235
Path Length M
T 2: The result of measurement of RNA level in CBAVD patient.
Nama Sampel A260 (AU) A280 (AU) A260/280 Konsentrasi (µg/ml)
Darah penderita CBAVD 0,1214 0,099 1,2235 24,28 µg / ml
Figure 3: Result showed negative adenovirus appear of PCR. bands features of ade-
novirus was not appear, primer of adenovirus with white band colour.
Line 4 : marker
protein Line 1,2,3,5,6,7,8,9,10 : sample
protein CFTR
A : ± 190 – 200
kDa
B : 170 – 180
T 3: The measurement of cDNA level in CBAVD patient.
Measurement Level
Wavelenght (1) 260 nm
Absorbance (1) 0,024 ÃU
Wavelenght (2) 280 nm
Absorbance (2) 0,025 ÃU
Concentration 0.0240 µg / ml X 200 = 4,8 µg / ml
Dilution Factor 1.000
Level of cDNA Ã 260 / Ã 280 : 0,9540
Path Length 1.00 cm
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T 4: The result of measurement cDNA level in CBAVD patient.
Nama Sampel A260 (AU) A280 (AU) A260/280 Konsentrasi (µg/ml)
Darahpenderita CBAVD 0,024 0,0250,9540 4,8 µg / ml






Cycling Step 1 @ 95∘c, hold 15
(40 repeats) secs
Step 2 @ 45∘c, hold 15
secs
Step 3 @ 60∘c, hold 45
secs, acquiring to
Cycling A([Green,1,1])
T 6: The parameter of amplifications cDNA procces in Rotor-Gene Mechine.
Step Result
Run Name IKA cDNA C M N
Run Start 1/17/2014 10:29:03 AM
Run Finish 1/17/2014 12:12:46 PM
Operator
Notes
Run On Software Version Rotor-Gene 2.0.2.4
Run Signature The Run Signature is valid.
Gain Green 9.33
Left Threshold 1.000
Standard Curve Imported No
Standard Curve (1) N/A
Standard Curve (2) N/A
Start normalising from cycle 1
Noise Slope Correction Yes
No Template Control Threshold 0%
Reaction Efficiency Threshold Disabled
Normalisation Method Dynamic Tube Normalisatio
Digital Filter Light
Sample Page Page 1
Imported Analysis Settings
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T 7: Profile of PCR programm in amplificate cDNA procces.
Cycle Cycle Point
Hold @ 95∘c,
0 min 15 secs
Cycling (40 repeats) Step 1 @ 95∘c, hold 15 secs
Step 2 @ 45∘c, hold 15 secs






hold 5 secs on
next steps, Melt A
([Green,1,1])
Figure 1: Graphic of the result reverse mRNA.
kDa
C : 140 – 160
kDa
D : ± 120 kDa
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Figure 2: Result of PCR.
T 8: The Result of Imunoglobulin G and Imunoglobulin A examination.
Measurement Result of Concentration Value Refference Apparatus Methode
Ig G 1579 mg/dL 700-1600mg/dL Cobas C6000 Imuno turbidimetri
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Figure 4: Result of SDS - PAGE CFTR Protein.
5. DISCUSSION
According to Center for Disease Control and Prevention (CDC), in US there are about 3%
children born suffering from various congenital defects every year and about 1 out of 5
babies with those congenital defects will die on their first year of living. The congenital
defect in Indonesia constitutes one of the causes of death of new born babies and if it
is not handled properly and quickly, it will become the lifelong defect able to increase
the rates of sickness and mortality of babies in Indonesia (WHO, 2010).
Infertility in men is still the case not yet having been completely and thoroughly
handled in Medical Science. Therefore, it is not only prioritized to do the genetic test to
the patient. Also, the etiology identification as well as the counseling shall have been
socialized in order to prevent the transmission of genetic defect through Assisted
Reproductive Technology (ART). The rate of CBAVD occurrence is certainly very small,
namely around 2 – 10%. However, if it is not properly handled, it will trigger the
occurrence of a problem, particularly the good harmony of a household.
The infertility identified by Azoospermia can be corrected through the surgery and
non-surgery actions. However, the surgical action still requires further experience and
research. In addition, there are many congenital defects unable to be given a therapy
or die at the early ages. Congenital defect can also cause the occurrence of mental
disorder.
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In Washington, the CBAVD cases are mostly dominated by the White-men. Based on
this case, a researchwas conducted at Pasteur Institute in1983 and it found out that the
possible cause of this case was CBAVD. The Diagnostic Researchwas developed and it
produced a Genetic Test Kit acknowledged byFDA at Robert Gallos Laboratory in 1985.
The screening program development has been activated pursuant to the speed rate
of the CBAVD case by performing “The Preconception and Prenatal Carrier Screening
for Cystic Fibrosis” in 2001 for the patient of CBAVD carrier. This was also conducted to
new born babies to perform the Newborn Screening through —Initial Screening Test
Level of IRT (Immuno Reactive Trypsinogen).
Output of this research proves the 3 different primaries, starting from the holding on
the fourth cycle and an increase continuously occurs till the 40𝑡ℎ cycle as an illustration
of cDNA profile of the CBAVD patients. This research also proves that the CBAVD con-
genital defect on Indonesian people have the chain of DNA gene CFTR length at about
400 base pair (400bp). Output of this research proves that the abnormal congenital
defect of the CBAVD on the Indonesian people has the chain of DNA gene CFTR at the
range of 400 base pair (400bp), whereas the European people have 600 base pair
(600bp). The difference in the output of this PCR is possibly influenced by various
factors, namely: total amount of samples being researched, research implementa-
tion technique covering the duration and temperature during annealing, cycling and
replication. Output of the SDS-PAGE analysis to determine the weight of CFTR protein
molecule is more or less 190 – 250 kDa, 170 – 180 kDa, 140 – 160 kDa and 120 kDa. The
long term objective of this research is to know how much the base pair of CBAVD case
in Indonesia is expected to become the prototype to repair the gene undergoing the
mutation as the result of congenital defect. The success of this research can give solu-
tion to the problem of CBAVD disease none the congenital defect due to the mutation
of ΔF 508-T gene coding the CFTR.
The finding of diagnostic through ART for CBAVD motivates the scientists to start
developing a research for CBAVD Therapy. In the year 1989, “Gene Testing Going
Mainstream” was invented to detect the gene mutation caused by Fibrosis Cys-
tic at the white people in Washington. (Wilschanski et al., 2000). At least 97% of
theFibrosisCystic cases on men with infertile condition but not sterile is due to the
occurrence of obstruction on ductus efferent and non-development of ductus deferens.
As a result it may have the potential to the occurrence of oligospermia, teratospermia,
and oligoastheno spermia.
Congenital Bilateral Absence of Vas Deferens (CBAVD) can reduce the volume of
spermatozoa then continued to cause the Infertility, so that it is able to decrease the
pregnancy. However, ART also has a weakness, namely progenitor supplementation
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that has to be carried out on the gene deletion already been cloned in order to design
the prototype on CBAVD disease. In addition, if the CBAVD case is not handled imme-
diately, it may cause the mortality because the fibrosis cystic has already undergone
the metastasis to various organs as the effect of gene mutation. CFTR of ΔF 508-T
mutant is the CFTR having got the deletion from phenylalanine at the position of 508
nucleotide base from the CFTR protein of coding gene at 554-576 region, so that the
chronology of amino acids of Isoleucine—Isoleucine—Glycine— Valine formerly from the
chronology of Ispoleucine–Isoleucine—Phenylalanine-Glycine—Valine and its nucleotide
chronology is ATC–ATT—GGT–GGT formerly from ATC—ATC—CTT—TTT—GGT— GTT (Cheng
et al., 1990). The success of this research can give solution to the problem of CBAVD
congenital defect as the effect of mutation of ΔF 508-T of CFTR coding gene.
The research conducted by ( Josserand et al., 2001) since December 1992 until
December 1999, 14 infertile male patients are positive CBAVD. The diagnosis that
was carried out for CBAVD patients is azoospermia, the size of testes that is smaller
than normal, no palpable pulse from vas deference, the ejaculation volume is low, the
semen pH is low, the fructose concentration is low, chlorid concentration > 60mmol,
respiratory disturbance, gastrointestinal and hepatobiliary.
This incident and congenital defect are different for different ethnic and race, same
goes to the calculation of how big and small the congenital defect is. More than 90%
babies born with serious congenitial defect are born in developed countries. From
the perinatal suvey, almost all developed countries has the perinatal ration bigger
than 1% and roughly 25% from this percentage dies from the direct effect of heavy
malformation (Arikrishnan, 2012).
Congenital defect in newly born babies can be one type of defect only or more than
one type of defect which is equivalent to multiple congenitial defect. One congenitial
defect is not found or not seen yet at newly born babies but these defect will only be
detected as the baby grows. As the development of the world of medicine increases,
one congenital defect can be identifies since foetus. When there are two or more
congenital defect found around 15% although there are only three or more small
congenital defect, the likelihood of finding large congenital defect is as big as 90%.
Major structural anomally happens 2-3% at newly born babies and other than that has
2-3% happens during 5 years of age or more until the total percentage is 4-6%. Birth
defect is the major cause of mortility in babies with the mortility around 21%.
The formation of organ which is known as organigenesis or morphogenesis is a
period that is really important to form a definitive individual (foetus). This mean that
the individual must have the shape and face that is specific in one species. During
organogenesis which is also called embryogenesis is a periode when all the germinal
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layers which is ectoderm, mesoderm and endoderm will form a lot of tissue and spe-
cific organs. The gonad and its ducts which is from the mesoderm layer will become
three layers which are epimere, mesomere and hipomere. Mesomere will develop into
Genitial ridge which will form reproductive organ and the urogenitial system while
Neprotome will form the kidney. Primordial germ cell will develop into Genitial Ridge
that will develop onto Gonadal Ridge and finally it will develop into gonad and will
migrate either pasively or actively until it become uterus, oviduct and vagia while the
Wollfian will become epididymis, vas defence and vas efferent (Poernomo dkk., 2012).
CFTR gene functions during the formation of mesonephricus duct until abnormal
defect of protein CFTR happens then systic fibrosis gene mutation will occur. The
mesonephric duct will not develop which will continue when there is no formation of
vas deferensand then, the spermatogenesis process will be affected as the volume of
sperm is low and the low quality of sperm. The indicator of systic fibrosis sometimes
cannot be diagnosed by CBAVD, then again, CBVAD always can be identidies when
there are presence of systic fibrosis ( Jiamin, 2012; Ven K, 1996).
Congenital Bilateral Absence of The Vas Deferens (CBAVD) is not very general as this
condition have prevalent around 1-2% from the male population (Durieu and Hollman,
1997). This CBAVD always caused by the obstruction of lateral Vas Deferens(Weiske
et al., 2000).
(Casals et al., 2000) reported that 38% from 138 people that suffer Congenital Uni-
latreal Absence Vas Deferenshas the relationship between mutation of CFTR and 45%
of patients suffering from this specific gene mutation is not found in cystic fibrosis.
This infertility case from 274 infectious male, only 3 that suffers CBAVD.
CFTR will cause systic fibrosis which is also known as mucoviscidosis and also a
genetic disease to the Western people which has prevalent 1:2000 of babies. CFTR is
due to the disturbance on the fuction of the exocrine gland with the characteristic of
this case where there is presence of chronic bronchopulmonary and disturbance of
the function of the pancreas. The function of the pancreas will effect the occurence of
malabsorbtion and continues when the growth is affected (Zabner et al., 1996).
At (Figure 4) the result of protein analysis to know the molecule weight of protein
CFTR at CBAVD patients is done by using SDS PAGE technique to explore the antigent
component based on molecule weight. The separation of protein molecule CFTR in
polyacrylamide gel is from the electronic mobility from one protein substance until
the mass protein separation is formed and the gel sheets is made through chemical
polimerisation from acrylamide and bisacrylamide. The CFTR is a primary protein chain
that contains 1480 amino acids which functions as cyclic AMP-regulated Cl-channel.
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6. CONCLUSION
This research shows that with three different primer which starting with holding at the
forth cycle and looking at the increment until the 40th cycle as a profile picture of cDNA
from CBAVD patients. Then, through this research, the congenital defect in Indonesian
people has DNA gene CFTR around 400 base pair (400bp). The difference in this PCR
value is maybe due to the factors that influence it like the samples, the technique
used during observations that involves time and temperature during annealing and
the replication cycle. The weight of the molecule from the analysis are ± 190 – 250
kDa, 170 - 180 k Da, 140 – 160 kDa and 120 kDa.
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